Best Clinical Research Paper:
2024: Salvage Hepatic Artery Infusion Chemotherapy after First Line Systemic Failure in Patients with Unresectable Cholangiocarcinoma, Misha Armstrong, MD
2021: Oral Paper 43: Neoadjuvant Chemotherapy-Associated Liver Injury in Pancreatic Cancer: Incidence and Implications, Erek Nelson, MD, Mayo Clinic, Rochester, MN
2020: Oral Paper 13: How Often Does Modern Neoadjuvant Chemotherapy (NAC) Downstage Patients to Breast-Conserving Surgery (BCS)?, Giacomo Montagna, MD, MPH and Oriana A. Petruolo, MD, Memorial Sloan Kettering Cancer Center, New York, NY
2019: Oral Paper 47: Predicting Risk of Recurrence After Colorectal Cancer Surgery in the United States: An Analysis of a Special Commission on Cancer National Study, Syed Nabeel Zafar, MD, MPH, The University of Texas MD Anderson Cancer Center, Houston, TX
2018: Oral Paper 4: Nodal Downstaging in Gastric Cancer: Promising Survival if ypN0 is Achieved, Naruhiko Ikoma, MD, MS, University of Texas MD Anderson Cancer Center, Houston, TX
2017: Oral Paper 30: Multi-Center Study of the Prognostic Value of Sentinel Lymph Node Biopsy in the Management of Recurrent Melanoma, Georgia Beasley, MD, The Ohio State University, Columbus, OH
2016: Oral Paper 24: How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients with Histologically Confirmed Nodal Metastases? Results of a Prospective Study, Anita Mamtani, MD, Memorial Sloan Kettering Cancer Center, New York, NY
2015: Oral Paper 10: Comparative Effectiveness of Primary Tumor Resection in Metastatic Colon Cancer: An Instrumental Variable Analysis, Zeinab Alawadi, MD, The University of Texas Health Science Center, Houston, TX
2014: Oral Paper 29: Preoperative Pancreastatin Predicts Survival in Neuroendocrine Tumors, Scott K. Sherman, MD, University of Iowa Department of Surgery, Iowa City, IA
2013: Oral Paper 74: Frequency and Intensity of Postoperative Surveillance after Curative Treatment of Pancreatic Cancer: A Cost-Effectiveness Analysis, Ching-Wei D. Tzeng, MD, MD Anderson Cancer Center, Houston, TX
2012: Oral Paper 16: The Impact of Vascular Reconstruction on Early Postoperative Outcomes After Pancreaticoduodenectomy: An Analysis of the American College of Surgeons National Surgical Quality Improvement Program Database, Anthony Castleberry, MD, Durham, NC
2011: Oral Paper 31: Needle versus Excisional Biopsy for Diagnosis of Breast Cancer, Richelle Williams, MD, University of Chicago Medical Center, Chicago, IL
2011: Oral Paper 66: A Novel C-terminal Hsp90 Inhibitor for Head and Neck Squamous Cell Cancer (HNSCC) with in vivo Efficacy, Stephanie Cohen, MD, University of Kansas Medical Center, Kansas City, KS
2010: Oral Paper 38: Surgical Management of Hepatic Neuroendocrine Tumor Metastasis, Skye Mayo, MD, Johns Hopkins University School of Medicine, Baltimore, MD
2010: Poster 113: Adjuvant Therapy for Resectable Pancreatic Cancer: A Simple Prediction Rule, Jillian Smith, MD, University of Massachusetts Medical School, Worcester, MA.
Best Basic Science Research Paper:
No Basic Science Research papers for 2019 or 2020
2024: Uveal Melanoma Immunogenomics Predict Immunotherapy Resistance and Susceptibility, Shravan Leonard-Murali, MD
2021: Oral Paper 19: Rapid Tumor Labeling Kinetics with a Site-specific Near-infrared Anti-CEA Nanobody in a Patient-Derived Mouse Model of Colon Cancer, Thinzar Lwin, MD, Dana Farber Cancer Center, West Roxbury, MA
2018: Oral Paper 71: Surgical Stress Suppresses Natural Killer Cell IFNy Release in Colorectal Cancer Patients, Andre B. Martel, MD, University of Ottawa, Ottawa, ON, Canada
2016: Oral Paper 75: Epigenetic Alterations and Canonical Pathway Disruption in Papillary Thyroid Cancer: A Genome Wide Methylation Analysis, Michael G. White, MD, University of Chicago, Pritzker School of Medicine, Chicago, IL
2015: Oral Paper 6: Proteomic Features of Colorectal Cancer Predict Relapse-free Survival and Identify Tumor Subgroups Independent of Oncogenic Mutations, Callisia Clarke, MD, MD Anderson Cancer Center, Houston, TX
2014: Oral Paper 95: A 13 Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest, Timothy Newhook, MD, University of Virginia, Department of Surgery, Charlottesville, VA
2013: Oral Paper 16: Peri-tumoral Expression of Adipokines and Fatty Acids in Breast Cancer, Jennifer L. Gnerlich, MD, The University of Chicago Medical Center, Chicago,IL
Best Disparities-related Paper:
2013: Oral Paper 23: Understanding Race-Related Colorectal Cancer Survival Disparities Race-related Colorectal Cancer Survival Disparity, Uma R. Phatak, MD, Center for Surgical Trials and Evidence-based Practice University of Texas Medical School at Houston, Houston, TX
2012: Poster 312: Socioeconomic and Geographic Disparities in Immediate Reconstruction after Mastectomy in the United States, Barbara Wexelman, MD, MBA, New York, NY
(Winners receive $600 cash and reimbursement of round-trip coach airfare to attend the meeting)
Poster Contest Winners
Best Basic & Translational Research Poster:
2021: Poster P5: Using the 21-Gene Recurrence Score as a Predictor of Response to Neoadjuvant Chemotherapy in Hormone Receptor Positive HER2 Negative Patients, Kaitlyn Kennard, MD, Lankenau Medical Center, Philadelphia, PA
2020: Poster P129: Peritoneal Cell-Free Tumor DNA as a Biomarker of Peritoneal Recurrence in Resected Pancreatic Cancers, Katie M. Leick, MD, MS, University of Iowa, Iowa City, IA
2019: Poster P185: The Association of PD-L1 Expression with Infiltrating Lymphocyte Densities in the Colon Adenocarcinoma Tumor Microenvironment on Endoscopic Biopsy and Final Pathology, Annelies T. Hickerson, MD, Brooke Army Medical Center, San Antonio, TX
2018: Poster PT1: Impact of Obesity on Breast Cancer Recurrence and Minimal Residual Disease, Brett Ecker, MD, University of Pennsylvania, Philadelphia, PA
2017: Poster PT181: Arid1a Deletion Results in Intraductal Papillary Mucinous Neoplasm Formation, Ibrahim Nassour, MD, The University of Texas Southwestern Medical Center, Dallas, TX
2016: Poster P388: The Necrosome Promotes Pancreatic Oncogenesis via CXCL1 and Mincle-Induced Immune Suppression, Gregor Werba, MD, NYU Langone Medical Center, New York, NY
2015: Poster P361: Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis, Amanda Kirane, UT Southwestern, Dallas, TX
2014: Poster P337: Primary Tumor in the Pancreas Potentiates the Formation of Liver Metastasis in a Murine Model of Pancreatic Cancer, Roheena Panni, Washington University in St. Louis, St. Louis, MO
2013: Poster P106: Colorectal Liver Metastases Demonstrate Sub-Populations with Differing Cancer Stem Cell Phenotypes in Xenograft and In Vitro Models, Dominic E. Sanford, MD, Washington University in St. Louis, St. Louis, MO
2012: Poster 5: Perioperative Sepsis, But not Hemorrhagic Shock Promotes the Development of Cancer Metastases in a Murine Model, Rashmi Seth, MD, Canada
2011: Poster 6, Serum Sphingosine -1-Phosphate Level in Breast Cancer Mouse Model and Patients, Masayuki Nagahashi, Surgical Oncology, Virginia Commonwealth University, Richmond, VA
2010: Poster 97, Low-Dose Metronomic Gemcitabine has High Antimetastatic Efficacy in an Orthotopic Mouse Model of Pancreatic Cancer. Author: Dr. H.S. Tran Cao, UC San Diego.
Best Clinical Research Poster:
2021: Poster P37: Comparison of Outcomes Between BRCA Mutation Carriers Undergoing Breast Conserving Surgery Versus Mastectomy, Sarah P. Shubeck, MD, MS, Memorial Sloan Kettering Cancer Center, New York, NY
2020: Poster P73: Radiation Only Adjuvant Therapy for Ductal Carcinoma In Situ Less Effective Than Endocrine Only or Radiation and Endocrine Therapy, Thomas O’Keefe, MD, University of California San Diego, San Diego, CA
2019: Poster P47: Impact of Age on Locoregional and Distant Recurrence After Mastectomy for DCIS With or Without Microinvasion, Anita Mamtani, MD, Memorial Sloan Kettering Cancer Center, New York, NY
2018: Poster PF169: Defining the Number of Lymph Nodes Needed to Accurately Stage Small Bowel Neuroendocrine Tumors: An Eight-Institution Study from the U.S. Neuroendocrine Tumor Study Group, Mohammad Y. Zaidi, MD, MS, Emory University, Atlanta, GA
2017: Poster PT24: Outcomes of Women with Minimal Volume Ductal Carcinoma in Situ Completely Excised on Core Biopsy, Shirin Muhsen, MD, Memorial Sloan Kettering Cancer Center, New York, NY
2016: Poster P16: Impact of the 70-Gene Signature on Adjuvant Systemic Therapy Decisions in Early Breast Cancer Patients: Preliminary Results of a Prospective Multicenter Observational Study, Anne Kuijer, MD, Diakonessenhuis Utrecht, Utrecht, Netherlands
2015: Poster P65: Over-utilization of Chest Computed Tomography in Stage I and II Breast Cancer Patients, Barbara Dull, MD Washington University, St. Louis, MO
2014: Poster P333: Is it Time to Abandon the 5cm Margin Rule During Resection of Distal Gastric Adenocarcinoma? A Multi-institution Study of the U.S. Gastric Cancer Collaborative, Malcolm H. Squires, Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA
2013: Poster P246: Obesity and Peritoneal Surface Disease: Outcomes Following Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Konstantinos I. Votanopoulos, MD, Wake Forest University, Winston Salem, NC
2012: Poster 258: Outcome after Therapeutic Lymph Node Dissection in Melanoma: Different Prognosis for Different Sites of Macrometastasis, Kevin Wevers, MD, The Netherlands
2011: Poster 9, sFRP1 Is a Prognostic Biomarker with Functional Significance in Gastric Cancer, Christopher Moran, MD, John Wayne Cancer Institute, Santa Monica, CA
2010: Poster 232, Role of Sentinel Lymph Node Biopsy in Anorectal Melanoma, P.F. McAuliffe, MD, from MD Anderson Cancer Center.